Dove Medical Press Ltd

SHERPA: Unknown

People

  1. Gulati
    Gulati
  2. Mcdevitt
    Mcdevitt
  3. Scheinberg
    Scheinberg
  4. Do
    Do
  5. Drilon
    Drilon
  6. Abida
    Abida
  7. Abou-Alfa
    Abou-Alfa
  8. Adusumilli
    Adusumilli
  9. Antonescu
    Antonescu
  10. Applebaum
    Applebaum

Groups

  1. Department of Medicine (27)
  2. Center for Hematologic Malignancies (14)
  3. Hematologic Malignancies, Division of (14)
  4. Anesthesiology Service (12)
  5. Anesthesiology and Critical Care Medicine (12)
  6. Solid Tumor Oncology Division (11)
  7. Adult Leukemia (7)
  8. Sloan Kettering Institute Postdocs (6)
  9. Surgery (6)
  10. Department of Pathology and Laboratory Medicine (5)
Search Within
Formats
  1. Journal Article (47)
  2. Review (22)
  3. Guidelines (4)
Groups
  1. Department of Medicine (27)
  2. Center for Hematologic Malignancies (14)
  3. Hematologic Malignancies, Division of (14)
  4. Anesthesiology Service (12)
  5. Anesthesiology and Critical Care Medicine (12)
  6. Solid Tumor Oncology Division (11)

More Groups

People
  1. Amitabh Gulati (12)
  2. Anthony Mato (3)
  3. David Scheinberg (3)
  4. Michael Mcdevitt (3)
  5. Alexander Drilon (2)
  6. Joseph Mulvey (2)

More People

Years
  1. 2025 (7)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Journal of Pain Research (12)
  2. Cancer Management and Research (10)
  3. OncoTargets and Therapy (10)
  4. Journal of Hepatocellular Carcinoma (4)
  5. Patient Preference and Adherence (4)
  6. Therapeutics and Clinical Risk Management (4)

More Publications

Results (73)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Potent in vitro and xenograft antitumor activity of a novel agent, PV-10, against relapsed and refractory neuroblastoma
    Journal Article

    Swift, L.; Zhang, C.; Trippett, T.; Narendran, A.
    OncoTargets and Therapy (2019)

    Fulltext@MSK | Save
  • Road map for fibrolamellar carcinoma: Progress and goals of a diversified approach
    Review

    Kastenhuber, E. R.; Craig, J.; Ramsey, J.; Sullivan, K. M.; Sage, J.; de Oliveira, S.; Riehle, K. J.; Scott, J. D.; Gordan, J. D.; Bardeesy, N.; more...
    Journal of Hepatocellular Carcinoma (2019)

    Fulltext@MSK | Save
  • LI-RADS: A conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance
    Review

    Elsayes, K. M.; Kielar, A. Z.; Chernyak, V.; Morshid, A.; Furlan, A.; Masch, W. R.; Marks, R. M.; Kamaya, A.; Do, R. K. G.; Kono, Y.; more...
    Journal of Hepatocellular Carcinoma (2019)

    Fulltext@MSK | Save
  • Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure
    Journal Article

    Bonafede, M.; Feliciano, J.; Cai, Q.; Noxon, V.; Princic, N.; Richhariya, A.; Straus, D. J.
    Clinicoeconomics and Outcomes Research (2018)

    Fulltext@MSK | Save
  • Entrectinib: An orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors
    Journal Article

    Liu, D.; Offin, M.; Harnicar, S.; Li, B. T.; Drilon, A.
    Therapeutics and Clinical Risk Management (2018)

    Fulltext@MSK | Save
  • The impact of coping strategies of cancer caregivers on psychophysiological outcomes: An integrative review
    Journal Article

    Teixeira, R. J.; Applebaum, A. J.; Bhatia, S.; Brandàƒo, T.
    Psychology Research and Behavior Management (2018)

    Fulltext@MSK | Save
  • The effects of amine-modified single-walled carbon nanotubes on the mouse microbiota
    Journal Article

    Mulvey, J. J.; Littmann, E. R.; Ling, L.; McDevitt, M. R.; Pamer, E. G.; Scheinberg, D. A.
    International Journal of Nanomedicine (2018)

    Fulltext@MSK | Save
  • Proton pump inhibitor-refractory gastroesophageal reflux disease: Challenges and solutions
    Journal Article

    Mermelstein, J.; Chait Mermelstein, A.; Chait, M. M.
    Clinical and Experimental Gastroenterology (2018)

    Fulltext@MSK | Save
  • Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies
    Journal Article

    Karantanos, T.; Politikos, I.; Boussiotis, V. A.
    Blood and Lymphatic Cancer: Targets and Therapy (2017)

    Fulltext@MSK | Save
  • The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
    Journal Article

    Sabari, J. K.; Santini, F. C.; Schram, A. M.; Bergagnini, I.; Chen, R.; Mrad, C.; Lai, W. V.; Arbour, K. C.; Drilon, A.
    OncoTargets and Therapy (2017)

    Fulltext@MSK | Save